Therapeutic Compounds Based on Pyrazolopyridine

Hirohito Katayama, Takafumi Mitsunaga, Atsushi Akahane, Youichi Shiokawa, Pyrazolopyridine compounds which have useful pharmaceutical utility ,(1992)

Robert W. Ward, Roger E. Markwell, Pyrazolopyridine derivatives useful in treating inflammation and allergic conditions ,(1986)

Serge Mignani, Conception Nemecek, Jean-Christophe Carry, Pyrrole derivatives, their preparation and pharmaceutical compositions containing them ,(1997)

Gary D Anderson, Susan A Gregory, Peter C Isakson, Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor ,(1996)

Ian Robert GlaxoSmithKline Baldwin, James Marvin GlaxoSmithKline Veal, Jennifer Badiang GlaxoSmithKline Stanford, Stuart GlaxoSmithKline Cockerill, Michael Robert GlaxoSmithKline Peel, Michael John GlaxoSmithKline Alberti, David Kendall GlaxoSmithKline Jung, Mui GlaxoSmithKline Cheung, Stephen Flack, Gregory GlaxoSmithKline Peckham, Philip Anthony Harris, Kirk GlaxoSmithKline Stevens, Fused pyrazole derivatives being protein kinase inhibitors ,(2001)

Brian A. GlaxoSmithKline Johns, Kristjan GlaxoSmithKline Gudmundsson, F.Leslie GlaxoSmithKline Boyd, Use of pyrazolopyridines as therapeutic compounds ,(2002)

Brian A. GlaxoSmithKline Johns, Kristjan GlaxoSmithKline Gudmundsson, Mui GlaxoSmithKline Cheung, Antiviral pyrazolopyridine compounds ,(2002)

Gary D. Anderson, Susan A. Gregory, Peter C. Isakson, Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor ,(1995)

Atsushi Akahane, Kieran P. M. Durkin, Shintaro Nishimura, Hiromichi Itani, Pyrazolopyridine adenosine antagonists ,(1994)

Michel Therien, Chun-Sing Li, Patrick Roy, Cheuk K. Lau, Jacques Yves Gauthier, Yves Leblanc, Zhaoyin Wang, Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents ,(1996)